These results confirmed our current hypothesis that serum levels of BDNF, NGF, 5-HT, and 5-HIAA are elevated after rTMS treatment and are positively correlated with improvements in cognitive function in patients with stroke. The gene discussed is NGF; the disease is Stroke.